David Steiger
Overview
Explore the profile of David Steiger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
247
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hasegawa D, Sato R, Lee Y, Wang H, Nishida K, Steiger D
Sci Rep
. 2024 Jul;
14(1):16049.
PMID: 38992133
The study aimed to evaluate the prevalence, risk factors, and clinical outcomes of pulmonary embolism in patients diagnosed with sepsis with and without shock. The National Inpatient Sample was used...
2.
Bell J, Lim S, Mikami T, Bahk J, Argiro S, Steiger D
Chron Respir Dis
. 2024 Mar;
21:14799731241242490.
PMID: 38545901
Objectives: We aimed to evaluate the utility of an Observation Unit (OU) in management of acute exacerbations of chronic obstructive pulmonary disease (AECOPD) and to identify the clinical characteristics of...
3.
Ishisaka Y, Watanabe A, Takagi H, Steiger D, Kuno T
Thromb Res
. 2023 Oct;
231:91-98.
PMID: 37839150
Introduction: Life-long anticoagulation is the recommended management for chronic thromboembolic pulmonary hypertension (CTEPH). Evidence regarding the use of direct oral anticoagulants (DOAC) for CTEPH is yet to be established. We...
4.
Ishisaka Y, Watanabe A, Fujisaki T, Iwagami M, So M, Steiger D, et al.
Catheter Cardiovasc Interv
. 2023 Jun;
102(2):249-265.
PMID: 37269229
Background: Multiple interventions, including catheter-directed therapy (CDT), systemic thrombolysis (ST), surgical embolectomy (SE), and therapeutic anticoagulation (AC) have been used to treat intermediate to high-risk pulmonary embolism (PE), but the...
5.
Olazagasti C, Seetharamu N, Kohn N, Steiger D
Lung Cancer Manag
. 2023 May;
11(2):LMT55.
PMID: 37122495
Aim: Lung cancer (LC) is the leading cause of cancer-related deaths worldwide. The US Preventive Services Task Force and National Comprehensive Cancer Network recommend annual low-dose computed tomography (LDCT) for...
6.
El Halabi M, Feghali J, Bahk J, Tallon de Lara P, Narasimhan B, Ho K, et al.
Intern Emerg Med
. 2022 Jun;
17(7):1879-1889.
PMID: 35773370
Predictive models for key outcomes of coronavirus disease 2019 (COVID-19) can optimize resource utilization and patient outcome. We aimed to design and internally validate a web-based calculator predictive of hospitalization...
7.
Rothman A, Lim S, Hasegawa D, Steiger D, Patel R, Lee Y
J Bronchology Interv Pulmonol
. 2021 Oct;
29(3):213-219.
PMID: 34693922
Background: Computed tomography (CT)-guided transthoracic needle biopsy is an important diagnostic tool for pulmonary nodules, offering a less invasive alternative to surgical procedures. This study aims to better risk stratify...
8.
Howell D, Verma H, Ho K, Narasimhan B, Steiger D, Rogers L
Expert Rev Respir Med
. 2021 Sep;
15(11):1377-1386.
PMID: 34570678
Introduction: Asthma is one of the most common chronic diseases worldwide. As a disease of the respiratory tract, the site of entry for the SARS-CoV-2 virus, there may be an...
9.
Ho K, Howell D, Rogers L, Narasimhan B, Verma H, Steiger D
Ann Allergy Asthma Immunol
. 2021 May;
127(2):279.
PMID: 33975023
No abstract available.
10.
Ho K, Narasimhan B, Difabrizio L, Rogers L, Bose S, Li L, et al.
BMJ Open Respir Res
. 2021 Apr;
8(1).
PMID: 33811098
Background: Corticosteroids are a potential therapeutic agent for patients with COVID-19 pneumonia. The RECOVERY (Randomised Trials in COVID-19 Therapy) trial provided data on the mortality benefits of corticosteroids. The study...